Small RNA interference-mediated ADP-ribosylation factor 6 silencing inhibits proliferation, migration and invasion of human prostate cancer PC-3 cells.
- Author:
Xiong-Wei SHAN
1
;
Shi-Dong LV
;
Xiao-Ming YU
;
Zheng-Fei HU
;
Jia-Jie ZHANG
;
Guang-Fa WANG
;
Qiang WEI
Author Information
- Publication Type:Journal Article
- MeSH: ADP-Ribosylation Factors; genetics; metabolism; Cell Line, Tumor; Cell Movement; Down-Regulation; Humans; Male; Mitogen-Activated Protein Kinase 1; metabolism; Mitogen-Activated Protein Kinase 3; metabolism; Neoplasm Invasiveness; Prostatic Neoplasms; pathology; RNA Interference; RNA, Messenger; genetics; metabolism; RNA, Small Interfering; genetics; Real-Time Polymerase Chain Reaction; Transfection; Wound Healing; rac1 GTP-Binding Protein; metabolism
- From: Journal of Southern Medical University 2016;36(6):735-743
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the effects of silencing ADP-ribosylation factor 6 (Arf6) on the proliferation, migration, and invasion of prostate cancer cell line PC-3 and the possible molecular mechanisms.
METHODSThree Arf6-specific small interfering RNA (siRNA) were transfected into cultured prostate cancer cell line PC-3. Arf6 expression was examined by real-time PCR and Western blotting. MTT assay, wound healing assay, and Transwell migration and invasion assay were used to observe the effect of Arf6 silencing on the proliferation, migration, and invasion ability of PC-3 cells. The levels of phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2), ERK1/2, p-AKT, AKT and Rac1 were detected by Western blotting.
RESULTSTransfection of siRNA-3 resulted in significantly decreased Arf6 mRNA and protein expression with inhibition rates of (91.88±3.13)% and (86.37±0.57)%, respectively. Arf6 silencing by siRNA-3 markedly suppressed the proliferation, migration and invasion of PC-3 cells and reduced the expression levels of p-ERK1/2 and Rac1.
CONCLUSIONSilencing of Arf6 efficiently inhibits the proliferation, migration, and invasion of PC-3 cells in vitro, and the underlying mechanisms may involve the down-regulation of p-ERK1/2 and Rac1.
